CyberAgent

CyberAgent is a Japanese internet services company that specializes in online advertising, gaming, and media. Founded in 1998 by Susumu Fujita, the company has grown to become one of the leading digital marketing and entertainment companies in Japan.

History

CyberAgent was established in Tokyo, Japan, with the aim of providing innovative internet services to users. The company initially focused on developing and operating online games, but later expanded its business to include various other digital services.

In 2000, CyberAgent launched its first online advertising platform, which allowed businesses to reach their target audience through targeted advertisements. This marked the beginning of the company's venture into the digital advertising industry.

Over the years, CyberAgent continued to diversify its portfolio by acquiring and investing in various companies. In 2008, the company acquired the social networking service operator, Mixi, which further strengthened its presence in the social media space.

Services

CyberAgent offers a wide range of services across different sectors of the digital industry. Some of its notable services include:

1. Online Advertising: CyberAgent provides digital advertising solutions to businesses, helping them reach their target audience effectively. The company's advertising platform utilizes advanced targeting technologies to deliver personalized advertisements to users.

2. Gaming: CyberAgent is involved in the development and operation of online games. The company has released several successful mobile games, including "Granblue Fantasy" and "Princess Connect! Re:Dive."

3. Media: CyberAgent operates various media platforms, including news websites and video streaming services. The company's media division focuses on delivering high-quality content to users, covering a wide range of topics such as entertainment, sports, and lifestyle.

Impact and Recognition

CyberAgent has made significant contributions to the digital industry in Japan and has gained recognition for its innovative services. The company has received several awards and accolades for its achievements, including being listed in Forbes' "Asia's 200 Best Under A Billion" list.

References

External links

Official website

Navigation: Wellness - Encyclopedia - Health topics - Disease Index‏‎ - Drugs - World Directory - Gray's Anatomy - Keto diet - Recipes

Transform your life with W8MD's budget GLP-1 injections from $125.

W8MD offers a medical weight loss program to lose weight in Philadelphia. Our physician-supervised medical weight loss provides:

- Weight loss injections in NYC (generic and brand names):
- Zepbound / Mounjaro, Wegovy / Ozempic, Saxenda
Most insurances accepted or discounted self-pay rates. We will obtain insurance prior authorizations if needed.
- Generic GLP1 weight loss injections from $125 for the starting dose.
Also offer prescription weight loss medications including Phentermine, Qsymia, Diethylpropion, Contrave etc.

NYC weight loss doctor appointments

Start your NYC weight loss journey today at our NYC medical weight loss and Philadelphia medical weight loss clinics.

Call 718-946-5500 to lose weight in NYC or for medical weight loss in Philadelphia 215-676-2334.
Tags:NYC medical weight loss, Philadelphia lose weight Zepbound NYC, Budget GLP1 weight loss injections, Wegovy Philadelphia, Wegovy NYC, Philadelphia medical weight loss, Brookly weight loss and Wegovy NYC

Advertise on WikiMD

WikiMD's Wellness Encyclopedia

Let Food Be Thy Medicine
Medicine Thy Food - Hippocrates

Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.